GeneNews Limited (TSE:GEN), a biotech junior, surged after announcing a partnership agreement with NueHealth, LLC
Sean Mason | September 19, 2016 | SmallCapPower
A blood sample processing agreement boosted a biotech junior Monday. Here’s some small stocks making big moves on Monday, September 19, 2016 (as of 4 pm EST):
GeneNews Limited (TSE:GEN) shares powered 41% higher to $0.275 on Monday after the biotech junior announced that it has entered into a partnership agreement with NueHealth, LLC, a privately-owned company that connects patients directly to physicians through integrated provider networks. GeneNews will process the blood samples for colorectal cancer, lung cancer and prostate cancer screening tests through its clinical reference laboratory in Richmond, Virginia.
As well, shares of Pangolin Diamonds Corp. (CVE:PAN) continued to slide Monday, down 17% to $0.05. On Friday, shares of the diamond explorer plunged 46% as the Company said material of interest from its wholly-owned Motloutse Diamond Project in Botswana has been analyzed by laboratories, which confirmed that no kimberlite was intersected.
Japan Gold Corp. (CVE:JG) stock, meanwhile, shot up 113% to $0.85 on the first day of trading following the July 6, 2016, announcement that the Company, formerly Sky Ridge Resources, will acquire Southern Arc Minerals Japan KK, becoming the first foreign mineral exploration company to focus solely on Japan. Japan Gold has filed 80 mineral prospecting license applications across eight distinct projects prospective for gold and porphyry mineralization.
Finally, SolidusGold Inc. (CVE:SDC) shares jumped 57% to $0.55 after the gold junior announced that it has entered into a definitive agreement with Newmont USA Limited to acquire the Northumberland Project in Nevada for US$20 million.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.
